CD19 and neoplasm: For instance, it has been demonstrated that chemokine (C-C motif) ligand 20 (CCL20) derived from tumor cells interacts with chemokine receptor 6 (CCR6) highly expressed by CD19+ CD5+ B cells, potentially enhancing angiogenesis and promoting HCC development [138].